| Synonyms: | |
| Status: | Approved (2018) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AA43 |
| UNII: | C3VX249T6L |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Complement C5 inhibitor | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hemoglobinuria, Paroxysmal | 4 | D006457 | ClinicalTrials |
| Myasthenia Gravis | 3 | D009157 | ClinicalTrials |
| Pneumonia, Viral | 3 | D011024 | ClinicalTrials |
| Respiratory Distress Syndrome | 3 | D012128 | ClinicalTrials |
| Thrombotic Microangiopathies | 3 | D057049 | ClinicalTrials |
| Acute Lung Injury | 3 | D055371 | ClinicalTrials |
| Atypical Hemolytic Uremic Syndrome | 3 | D065766 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis | 3 | D000690 | ClinicalTrials |
| Neuromyelitis Optica | 3 | D009471 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3989986 |
| FDA SRS | C3VX249T6L |
CONTENTS